HK1038918A1 - 蕈毒碱性激動劑與拮抗劑 - Google Patents

蕈毒碱性激動劑與拮抗劑

Info

Publication number
HK1038918A1
HK1038918A1 HK02100409.3A HK02100409A HK1038918A1 HK 1038918 A1 HK1038918 A1 HK 1038918A1 HK 02100409 A HK02100409 A HK 02100409A HK 1038918 A1 HK1038918 A1 HK 1038918A1
Authority
HK
Hong Kong
Prior art keywords
antagonists
muscarinic agonists
muscarinic
agonists
Prior art date
Application number
HK02100409.3A
Other languages
English (en)
Inventor
G‧格雷瓦爾
A‧特伊-帕爾莫
蔡雄
G‧M‧拉薩姆
Original Assignee
Ucb公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb公司 filed Critical Ucb公司
Publication of HK1038918A1 publication Critical patent/HK1038918A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK02100409.3A 1998-08-18 2002-01-18 蕈毒碱性激動劑與拮抗劑 HK1038918A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9697798P 1998-08-18 1998-08-18
PCT/US1999/018570 WO2000011001A1 (en) 1998-08-18 1999-08-16 Muscarinic agonists and antagonists

Publications (1)

Publication Number Publication Date
HK1038918A1 true HK1038918A1 (zh) 2002-04-04

Family

ID=22260061

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02100409.3A HK1038918A1 (zh) 1998-08-18 2002-01-18 蕈毒碱性激動劑與拮抗劑

Country Status (30)

Country Link
US (5) US6093724A (zh)
EP (1) EP1112272B1 (zh)
JP (1) JP2002523416A (zh)
KR (1) KR20010072784A (zh)
CN (1) CN1312812A (zh)
AR (1) AR020199A1 (zh)
AT (1) ATE227724T1 (zh)
AU (1) AU750566B2 (zh)
BG (1) BG105256A (zh)
BR (1) BR9913072A (zh)
CA (1) CA2340946A1 (zh)
CO (1) CO5130018A1 (zh)
DE (1) DE69903961T2 (zh)
EE (1) EE200100096A (zh)
ES (1) ES2191455T3 (zh)
HK (1) HK1038918A1 (zh)
HU (1) HUP0103203A3 (zh)
ID (1) ID27544A (zh)
IL (1) IL141050A0 (zh)
IS (1) IS5827A (zh)
NO (1) NO20010804L (zh)
NZ (1) NZ509762A (zh)
PE (1) PE20000988A1 (zh)
PL (1) PL346247A1 (zh)
RU (1) RU2219179C2 (zh)
SK (1) SK1892001A3 (zh)
TR (1) TR200100462T2 (zh)
WO (1) WO2000011001A1 (zh)
YU (1) YU13301A (zh)
ZA (1) ZA200100978B (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0301442A3 (en) * 2000-10-19 2007-03-28 Pfizer Prod Inc Bridged piperazine derivatives and pharmaceutical compositions containing them
GB0117950D0 (en) * 2001-02-16 2001-09-19 Aventis Pharma Inc Novel heterocyclic urea derivatives andd their use as dopamine D3 receptor ligands
WO2002094827A1 (en) * 2001-05-23 2002-11-28 Neurosearch A/S Fused tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US20030064979A1 (en) * 2001-06-29 2003-04-03 Hansen Thomas Kruse Method of inhibiting PTP 1B and /or T-cell PTP and/or other PTPases with an Asp residue at position 48
US6828328B1 (en) * 2002-03-01 2004-12-07 Ucb S.A. Analgesic combination of muscarinic agonists
US7897766B2 (en) 2005-09-23 2011-03-01 Abbott Laboratories Amino-aza-adamantane derivatives and methods of use
US8314119B2 (en) * 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
US8076350B2 (en) 2006-12-22 2011-12-13 Abbott Laboratories Spirocyclic azaadamantane derivatives and methods of use
MX2009010175A (es) * 2007-03-23 2009-10-12 Abbott Lab Derivados de acetamida y carboxamida de aza-adamantano y metodos de uso de los mismos.
US8163915B2 (en) * 2007-03-23 2012-04-24 Abbott Laboratories 4-substituted azaadamantane derivatives and methods of use thereof
RU2549551C2 (ru) * 2009-06-19 2015-04-27 Эббви Инк. Производные диазагомоадамантана и способы их применения
US10265311B2 (en) 2009-07-22 2019-04-23 PureTech Health LLC Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
HUE044653T2 (hu) 2009-07-22 2019-11-28 PureTech Health LLC Készítmények olyan rendellenességek kezelésére, amelyek muszkarin-receptor aktiválással enyhíthetõk
EP2560488B1 (en) 2010-04-23 2015-10-28 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
WO2012040404A1 (en) * 2010-09-23 2012-03-29 Abbott Laboratories Monohydrate of an azaadamantane derivative
US8759380B2 (en) 2011-04-22 2014-06-24 Cytokinetics, Inc. Certain heterocycles, compositions thereof, and methods for their use
US11325896B2 (en) 2017-12-20 2022-05-10 Vanderbilt University Antagonists of the muscarinic acetylcholine receptor M4
SG11202102349PA (en) 2018-09-28 2021-04-29 Karuna Therapeutics Inc Compositions and methods for treating disorders ameliorated by muscarnic receptor activation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4739074A (en) * 1986-01-22 1988-04-19 Pennwalt Corporation Adamantane spiro-pyrrolidine derivatives
IL88156A (en) * 1987-11-13 1997-02-18 Novo Nordisk As Azacyclic compounds their preparation and pharmaceutical compositions containing them
US5527813A (en) * 1990-08-21 1996-06-18 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
EP0563036A1 (en) * 1990-12-21 1993-10-06 Merck Sharp & Dohme Ltd. 4-azatricyclo 2.2.1.0?2,6 ]heptanes and pharmaceutical compositions
US5955470A (en) * 1991-06-11 1999-09-21 Merrell Pharmaceuticals, Inc. Derivatives of amide analogs of certain methano bridged quinolizines
US5641791A (en) * 1991-08-13 1997-06-24 Novo Nordisk A.S Heterocyclic compounds and their preparation and use
US5998405A (en) * 1995-11-02 1999-12-07 Neurosearch A/S Fused tropane-derivatives as neurotransmitter reuptake inhibitors
US5914338A (en) * 1996-04-02 1999-06-22 Novo Nordisk Heterocyclic compounds and their preparation and use
US6057446A (en) * 1998-04-02 2000-05-02 Crooks; Peter Anthony Certain 1-aza-tricyclo [3.3.1-13,7 ] decane compounds
US5952339A (en) * 1998-04-02 1999-09-14 Bencherif; Merouane Pharmaceutical compositions and methods of using nicotinic antagonists for treating a condition or disorder characterized by alteration in normal neurotransmitter release
US5986100A (en) * 1998-04-02 1999-11-16 Crooks; Peter Anthony Pharmaceutical compositions and methods for use

Also Published As

Publication number Publication date
JP2002523416A (ja) 2002-07-30
CA2340946A1 (en) 2000-03-02
ZA200100978B (en) 2002-02-05
AU5775899A (en) 2000-03-14
US6555550B1 (en) 2003-04-29
CO5130018A1 (es) 2002-02-27
RU2219179C2 (ru) 2003-12-20
ID27544A (id) 2001-04-12
US6323194B1 (en) 2001-11-27
US6423842B1 (en) 2002-07-23
PL346247A1 (en) 2002-01-28
IS5827A (is) 2001-01-26
BR9913072A (pt) 2001-05-15
PE20000988A1 (es) 2000-09-30
YU13301A (sh) 2005-06-10
SK1892001A3 (en) 2001-11-06
EP1112272A1 (en) 2001-07-04
NO20010804L (no) 2001-04-11
ES2191455T3 (es) 2003-09-01
BG105256A (en) 2001-11-30
NZ509762A (en) 2002-12-20
HUP0103203A3 (en) 2002-10-28
US6251916B1 (en) 2001-06-26
TR200100462T2 (tr) 2001-09-21
ATE227724T1 (de) 2002-11-15
IL141050A0 (en) 2002-02-10
NO20010804D0 (no) 2001-02-16
AU750566B2 (en) 2002-07-25
HUP0103203A2 (hu) 2002-01-28
WO2000011001A1 (en) 2000-03-02
DE69903961T2 (de) 2003-07-03
AR020199A1 (es) 2002-05-02
EE200100096A (et) 2002-06-17
CN1312812A (zh) 2001-09-12
US6093724A (en) 2000-07-25
US20020045617A1 (en) 2002-04-18
EP1112272B1 (en) 2002-11-13
KR20010072784A (ko) 2001-07-31
DE69903961D1 (de) 2002-12-19

Similar Documents

Publication Publication Date Title
IL139136A0 (en) Il-2 selective agonists and antagonists
PL331534A1 (en) Muscarinic antagonists
IL141050A0 (en) Muscarinic agonists and antagonists
GB9812413D0 (en) Compound and its use
GB9813271D0 (en) Composition and use
IL140249A0 (en) Muscarinic antagonists
SG80041A1 (en) Muscarinic receptor antagonists
HUP0203896A3 (en) Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof
AUPP380498A0 (en) Egf receptor agonists and antagonists
EP1056455A4 (en) EPIMORPHIN COMPOUND AND USE OF THE SAME
PL332616A1 (en) Hydoxymethylhexanones as odorising and savourising agents
GB9803232D0 (en) Compound composition and use
HK1043590A1 (zh) 毒蕈碱性拮抗物
EP1242074A4 (en) NMDA / NR2B ANTAGONISTS BASED ON 5-BENZYL-OCTAHYDROINDOLE AND 6-BENZYL-DECAHYDROQUINOLINE
HUP0004317A3 (en) 5-ht1f agonists
AU9275001A (en) Notch receptor agonists and uses
GB9820014D0 (en) Receptor antagonists and uses thereof
AU5861900A (en) Receptor agonists and antagonists
GB9701374D0 (en) Purinergic agonists and antagonists
HU9902674D0 (en) Estrogen agonists/antagonists
IL137428A0 (en) Estrogen agonists and antagonists for multiple indications
PL307138A1 (en) Amyline antagonists and agonists
GB9911606D0 (en) Composition and use
GB9805172D0 (en) Composition and use
GB9719843D0 (en) Intergrin antagonists